中国全科医学2017，Vol.20Issue(2)：228-231,4.DOI:10.3969/j.issn.1007-9572.2017.02.022
哮喘生物标志物研究新进展
Research Progress of Biomarker in Asthma
摘要
Abstract
Asthma is a heterogeneous syndrome. Classification of asthma into phenotypes is conducive to the diagnosis,treatment and management of the disease. Traditional methods are inadequate in achieving an early diagnosis, assessment of disease staging and phenotype,and in the monitoring of therapeutic responses. Identification and utilization of biomarkers can help group patients into phenotypes,predict the response to treatment,determine the therapeutic regimen as well as provide new thoughts for understanding the pathogenesis and phenotype of asthma and initiating new targets for drug therapy. This paper reviewed biomarkers for the diagnosis and evaluation of asthma from three aspects,including asthma phenotypes, assessment of the severity of asthma,and the study of biomarkers.关键词
哮喘/生物学标记/综述Key words
Asthma/Biological markers/Review分类
医药卫生引用本文复制引用
孙莉,陈清阁,倪振华,赖一鸣,王雄彪..哮喘生物标志物研究新进展[J].中国全科医学,2017,20(2):228-231,4.基金项目
国家自然科学基金资助项目（81402988）；普陀区高层次人才科研创新项目 （）
